124 related articles for article (PubMed ID: 38723105)
21. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
22. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic diseases associated with thymoma.
Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus.
Takeuchi Y; Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
Cell Immunol; 1995 Apr; 161(2):181-7. PubMed ID: 7697728
[TBL] [Abstract][Full Text] [Related]
25. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.
Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y
Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and functional maturation of TCR gammadelta cells in the human thymus.
Offner F; Van Beneden K; Debacker V; Vanhecke D; Vandekerckhove B; Plum J; Leclercq G
J Immunol; 1997 May; 158(10):4634-41. PubMed ID: 9144475
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors.
Fujii Y; Okumura M; Yamamoto S
J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845
[TBL] [Abstract][Full Text] [Related]
28. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
30. TGF-β cytokine signaling promotes CD8+ T cell development and low-affinity CD4+ T cell homeostasis by regulation of interleukin-7 receptor α expression.
Ouyang W; Oh SA; Ma Q; Bivona MR; Zhu J; Li MO
Immunity; 2013 Aug; 39(2):335-46. PubMed ID: 23932572
[TBL] [Abstract][Full Text] [Related]
31. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
32. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
33. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
34. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
35. The long-term survival potential of mature T lymphocytes is programmed during development in the thymus.
Sinclair C; Saini M; Schim van der Loeff I; Sakaguchi S; Seddon B
Sci Signal; 2011 Nov; 4(199):ra77. PubMed ID: 22087033
[TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.
Ferone D; Kwekkeboom DJ; Pivonello R; Bogers ADColao A; Lamberts SW; van Hagen PM; Hofland LJ
J Endocrinol Invest; 2001; 24(7):522-8. PubMed ID: 11508787
[TBL] [Abstract][Full Text] [Related]
37. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus.
Marchevsky AM; Walts AE
Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267
[TBL] [Abstract][Full Text] [Related]
38. T lymphocyte activation in myasthenic thymoma.
Takahashi K; Saito S; Monden Y
Autoimmunity; 1998; 28(3):173-82. PubMed ID: 9867130
[TBL] [Abstract][Full Text] [Related]
39. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
40. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]